Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>

<i>Enterococcus faecium</i> has become an important drug-resistant nosocomial pathogen because of widespread antibiotic abuse. We developed short and chemically simple antimicrobial peptides (AMPs) with a selective amino acid composition, fixed charge, and hydrophobicity ratio based on t...

Full description

Bibliographic Details
Main Authors: Biswajit Mishra, LewisOscar Felix, Anindya Basu, Sai Sundeep Kollala, Yashpal Singh Chhonker, Narchonai Ganesan, Daryl J. Murry, Eleftherios Mylonakis
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/8/1085
_version_ 1797432589443661824
author Biswajit Mishra
LewisOscar Felix
Anindya Basu
Sai Sundeep Kollala
Yashpal Singh Chhonker
Narchonai Ganesan
Daryl J. Murry
Eleftherios Mylonakis
author_facet Biswajit Mishra
LewisOscar Felix
Anindya Basu
Sai Sundeep Kollala
Yashpal Singh Chhonker
Narchonai Ganesan
Daryl J. Murry
Eleftherios Mylonakis
author_sort Biswajit Mishra
collection DOAJ
description <i>Enterococcus faecium</i> has become an important drug-resistant nosocomial pathogen because of widespread antibiotic abuse. We developed short and chemically simple antimicrobial peptides (AMPs) with a selective amino acid composition, fixed charge, and hydrophobicity ratio based on the core antimicrobial motif of bovine lactoferrin (LfcinB6). Among these peptides, 5L and 6L (both 12 residues long) demonstrated a narrow spectrum and high antibacterial activity against drug-resistant <i>E. faecium</i> isolates with a minimal inhibitory concentration (MIC) that ranged from 4–16 µg/mL. At 32 µg/mL, peptides 5L and 6L inhibited <i>E. faecium</i> strain C68 biofilm formation by 90% and disrupted established biofilms by 75%. At 40 µg/mL, 5L reduced 1 × 10<sup>7</sup><i>E. faecium</i> persister cells by 3 logs within 120 min of exposure, whereas 6L eliminated all persister cells within 60 min. At 0.5× MIC, 5L and 6L significantly downregulated the expression of a crucial biofilm gene <i>ace</i> by 8 folds (<i>p</i> = 0.02) and 4 folds (<i>p</i> = 0.01), respectively. At 32 µg/mL, peptides 5L and 6L both depolarized the <i>E. faecium</i> membrane, increased fluidity, and eventually ruptured the membrane. Physiologically, 5L (at 8 µg/mL) altered the tricarboxylic acid cycle, glutathione, and purine metabolism. Interestingly, in an ex vivo model of porcine skin infection, compared to no treatment, 5L (at 10× MIC) effectively eliminated all 1 × 10<sup>6</sup> exponential (<i>p</i> = 0.0045) and persister <i>E. faecium</i> cells (<i>p</i> = 0.0002). In conclusion, the study outlines a roadmap for developing narrow-spectrum selective AMPs and presents peptide 5L as a potential therapeutic candidate to be explored against <i>E. faecium</i>.
first_indexed 2024-03-09T10:02:48Z
format Article
id doaj.art-c0ddb70f1a88495f85f16e37cc6c123c
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T10:02:48Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-c0ddb70f1a88495f85f16e37cc6c123c2023-12-01T23:19:39ZengMDPI AGAntibiotics2079-63822022-08-01118108510.3390/antibiotics11081085Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>Biswajit Mishra0LewisOscar Felix1Anindya Basu2Sai Sundeep Kollala3Yashpal Singh Chhonker4Narchonai Ganesan5Daryl J. Murry6Eleftherios Mylonakis7Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USAInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USASchool of Pharmaceutical Sciences, Rajiv Gandhi Technological University, Bhopal 462033, IndiaDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USADepartment of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USAInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USADepartment of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USAInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA<i>Enterococcus faecium</i> has become an important drug-resistant nosocomial pathogen because of widespread antibiotic abuse. We developed short and chemically simple antimicrobial peptides (AMPs) with a selective amino acid composition, fixed charge, and hydrophobicity ratio based on the core antimicrobial motif of bovine lactoferrin (LfcinB6). Among these peptides, 5L and 6L (both 12 residues long) demonstrated a narrow spectrum and high antibacterial activity against drug-resistant <i>E. faecium</i> isolates with a minimal inhibitory concentration (MIC) that ranged from 4–16 µg/mL. At 32 µg/mL, peptides 5L and 6L inhibited <i>E. faecium</i> strain C68 biofilm formation by 90% and disrupted established biofilms by 75%. At 40 µg/mL, 5L reduced 1 × 10<sup>7</sup><i>E. faecium</i> persister cells by 3 logs within 120 min of exposure, whereas 6L eliminated all persister cells within 60 min. At 0.5× MIC, 5L and 6L significantly downregulated the expression of a crucial biofilm gene <i>ace</i> by 8 folds (<i>p</i> = 0.02) and 4 folds (<i>p</i> = 0.01), respectively. At 32 µg/mL, peptides 5L and 6L both depolarized the <i>E. faecium</i> membrane, increased fluidity, and eventually ruptured the membrane. Physiologically, 5L (at 8 µg/mL) altered the tricarboxylic acid cycle, glutathione, and purine metabolism. Interestingly, in an ex vivo model of porcine skin infection, compared to no treatment, 5L (at 10× MIC) effectively eliminated all 1 × 10<sup>6</sup> exponential (<i>p</i> = 0.0045) and persister <i>E. faecium</i> cells (<i>p</i> = 0.0002). In conclusion, the study outlines a roadmap for developing narrow-spectrum selective AMPs and presents peptide 5L as a potential therapeutic candidate to be explored against <i>E. faecium</i>.https://www.mdpi.com/2079-6382/11/8/1085antimicrobial peptidesbiofilmpersisters<i>Enterococcus faecium</i>
spellingShingle Biswajit Mishra
LewisOscar Felix
Anindya Basu
Sai Sundeep Kollala
Yashpal Singh Chhonker
Narchonai Ganesan
Daryl J. Murry
Eleftherios Mylonakis
Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
Antibiotics
antimicrobial peptides
biofilm
persisters
<i>Enterococcus faecium</i>
title Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
title_full Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
title_fullStr Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
title_full_unstemmed Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
title_short Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant <i>Enterococcus faecium</i>
title_sort design and evaluation of short bovine lactoferrin derived antimicrobial peptides against multidrug resistant i enterococcus faecium i
topic antimicrobial peptides
biofilm
persisters
<i>Enterococcus faecium</i>
url https://www.mdpi.com/2079-6382/11/8/1085
work_keys_str_mv AT biswajitmishra designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT lewisoscarfelix designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT anindyabasu designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT saisundeepkollala designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT yashpalsinghchhonker designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT narchonaiganesan designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT daryljmurry designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi
AT eleftheriosmylonakis designandevaluationofshortbovinelactoferrinderivedantimicrobialpeptidesagainstmultidrugresistantienterococcusfaeciumi